| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Department of Surgery I, Oita Medical University,Oita, Japan.
Correspondence: Address correspondence and reprint requests to: Kazuhiro Yasuda, MD, Department of Surgery I, Oita Medical University, 1-1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan; Fax: 81-97-549-6039.
Background: Studies of lymph node micrometastases in patients with colorectal cancer have ignored the prognostic significance of the number and level of lymph node micrometastases. The aim of this study was to clarify the prognostic significance of the status of lymph node micrometastases in histologically node-negative colorectal cancer.
Methods: We used immunohistochemistry with anti-cytokeratin antibody CAM5.2 to examine 1013 lymph nodes in 42 patients (12 recurrent and 30 nonrecurrent) with histologically determined Dukes B colorectal cancer. Five serial 6-µm sections were used for immunohistochemical staining. The frequency, tumor cell pattern, and number and level of lymph node micrometastases were compared between the recurrent and nonrecurrent groups.
Results: Micrometastasis was confirmed in 16% (59/373) of lymph nodes in the recurrent group and 12% (77/640) of lymph nodes in the nonrecurrent group, and the frequency of lymph node micrometastases was 92% (11/12) in the recurrent group and 70% (21/30) in the nonrecurrent group. The tumor cell pattern in the metastatic lymph nodes was similar in the recurrent and nonrecurrent groups. Micrometastasis in four or more lymph nodes occurred more frequently in the recurrent group than in the nonrecurrent group (58% vs. 20%, P < .05), and micrometastasis to N2 or higher nodes occurred more frequently in the recurrent group than in the nonrecurrent group (92% vs. 47%, P < .01).
Conclusions: The number and level of positive micrometastatic lymph nodes was significantly correlated with postoperative recurrence of histologically determined Dukes B colorectal cancer. This parameter is a useful prognostic indicator in histologically node-negative colorectal cancer and is helpful in planning adjuvant chemotherapy.
Key Words: Colorectal cancer Lymph node micrometastasis Micrometastasis Immunohistochemistry Cytokeratin Prognosis
This article has been cited by other articles:
![]() |
R. Steinert, M. Hantschick, M. Vieth, I. Gastinger, F. Kuhnel, H. Lippert, and M. A. Reymond Influence of Subclinical Tumor Spreading on Survival After Curative Surgery for Colorectal Cancer Arch Surg, February 1, 2008; 143(2): 122 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Turner, C. Li, and C. C. Compton Newer Pathologic Assessment Techniques for Colorectal Carcinoma Clin. Cancer Res., November 15, 2007; 13(22): 6871s - 6876s. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Nicastri, J. T. Doucette, T. E. Godfrey, and S. J. Hughes Is Occult Lymph Node Disease in Colorectal Cancer Patients Clinically Significant?: A Review of the Relevant Literature J. Mol. Diagn., November 1, 2007; 9(5): 563 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. de Haas, D. A. Wicherts, M. G. G. Hobbelink, I. H. M. B. Rinkes, M. E. I. Schipper, J.-A. van der Zee, and R. van Hillegersberg Sentinel Lymph Node Mapping in Colon Cancer: Current Status Ann. Surg. Oncol., March 1, 2007; 14(3): 1070 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Iddings, A. Ahmad, D. Elashoff, and A. Bilchik The Prognostic Effect of Micrometastases in Previously Staged Lymph Node Negative (N0) Colorectal Carcinoma: A Meta-analysis Ann. Surg. Oncol., November 1, 2006; 13(11): 1386 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Mescoli, M Rugge, S Pucciarelli, V M Russo, G Pennelli, M Guido, and D Nitti High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer J. Clin. Pathol., August 1, 2006; 59(8): 870 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Bilchik, M. DiNome, S. Saha, R. R. Turner, D. Wiese, M. McCarter, D. S. B. Hoon, and D. L. Morton Prospective Multicenter Trial of Staging Adequacy in Colon Cancer: Preliminary Results Arch Surg, June 1, 2006; 141(6): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohrling, D. Edler, M. Hallstrom, P. Ragnhammar, and H. Blomgren Detection of Thymidylate Synthase Expression in Lymph Node Metastases of Colorectal Cancer Can Improve the Prognostic Information J. Clin. Oncol., August 20, 2005; 23(24): 5628 - 5634. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Compton and F. L. Greene The Staging of Colorectal Cancer: 2004 and Beyond CA Cancer J Clin, November 1, 2004; 54(6): 295 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Shores, X. Yin, W. Funkhouser, and W. Yarbrough Clinical Evaluation of a New Molecular Method for Detection of Micrometastases in Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, August 1, 2004; 130(8): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Onate-Ocana, R. Montesdeoca, C. M. Lopez-Graniel, V. Aiello-Crocifoglio, R. Mondragon-Sanchez, M. Cortina-Borja, R. Herrera-Goepfert, C. Oros-Ovalle, and D. Gallardo-Rincon Identification of Patients with High-risk Lymph Node-negative Colorectal Cancer and Potential Benefit from Adjuvant Chemotherapy Jpn. J. Clin. Oncol., June 1, 2004; 34(6): 323 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Greene, A. K. Stewart, and H. J. Norton New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An Analysis J. Clin. Oncol., May 15, 2004; 22(10): 1778 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Doekhie, K. C. M. J. Peeters, R. A. E. M. Tollenaar, and C. J. H. van de Velde Minimal Residual Disease Assessment in Sentinel Nodes of Breast and Gastrointestinal Cancer: A Plea for Standardization Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 236S - 241S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Mesker, F. S. Doekhie, H. Vrolijk, R. Keyzer, W. C. R. Sloos, H. Morreau, P. S. O'Kelly, G. H. de Bock, R. A. E. M. Tollenaar, and H. J. Tanke Automated Analysis of Multiple Sections for the Detection of Occult Cells in Lymph Nodes Clin. Cancer Res., October 15, 2003; 9(13): 4826 - 4834. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Feezor, E. M. Copeland III, and S. N. Hochwald Significance of Micrometastases in Colorectal Cancer Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953. [Full Text] [PDF] |
||||
![]() |
S. Noura, H. Yamamoto, T. Ohnishi, N. Masuda, T. Matsumoto, O. Takayama, H. Fukunaga, Y. Miyake, M. Ikenaga, M. Ikeda, et al. Comparative Detection of Lymph Node Micrometastases of Stage II Colorectal Cancer by Reverse Transcriptase Polymerase Chain Reaction and Immunohistochemistry J. Clin. Oncol., October 15, 2002; 20(20): 4232 - 4241. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasuda, Y. Adachi, N. Shiraishi, M. Inomata, H. Takeuchi, and S. Kitano Prognostic Effect of Lymph Node Micrometastasis in Patients With Histologically Node-Negative Gastric Cancer Ann. Surg. Oncol., October 1, 2002; 9(8): 771 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Noura, H. Yamamoto, Y. Miyake, B. no Kim, O. Takayama, I. Seshimo, M. Ikenaga, M. Ikeda, M. Sekimoto, N. Matsuura, et al. Immunohistochemical Assessment of Localization and Frequency of Micrometastases in Lymph Nodes of Colorectal Cancer Clin. Cancer Res., March 1, 2002; 8(3): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Niederhuber The Future for Staging of Primary Tumors Ann. Surg. Oncol., June 1, 2001; 8(5): 384 - 385. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |